3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Multiple Myeloma
2
Lymphoma, B-Cell
2
Lymphoma
2
Neurotoxicity Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Hodgkin Disease
1
Cytokine Release Syndrome
1
Interventions
siltuximab
2
fludarabine phosphate
2
fludarabine
2
Interleukin 1 Receptor Antagonist Protein
2
Cyclophosphamide
2
AP 1903 reagent
2
obinutuzumab
1
glofitamab
1
axicabtagene ciloleucel
1
Oxaliplatin
1
Neuropsychological Tests
1
Magnetic Resonance Spectroscopy
1
Gemcitabine
1
Gelsolin
1
Contrast Media
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytokine Release Syndrome
×
Neuropsychological Tests
×
Lymphoid
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled